Universal-Beteiligungs- und Servicegesellschaft
DFTX

Universal-Beteiligungs- und Servicegesellschaft’s Definium Therapeutics DFTX Stock Holding History

Universal-Beteiligungs- und Servicegesellschaft’s Portfolio DFTX Stock Details DFTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-278,720
Closed -$3.73M – 2113
2025
Q4 		$3.73M Buy
+278,720
New +$3.45M 0.01% 1020

Other funds holding DFTX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
OCA
Octagon Capital Advisors New York $904M AUM 737.04% 1-Year Est. Return
CC
Commodore Capital New York $1.73B AUM 298.96% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Universal-Beteiligungs- und Servicegesellschaft's DFTX Position: Q1 2026 in Review

Universal-Beteiligungs- und Servicegesellschaft sold out of Definium Therapeutics (DFTX) in Q1 2026, closing a stake of 278,720 shares — an estimated $3.73M sold.

Universal-Beteiligungs- und Servicegesellschaft first reported a position in DFTX in Q4 2025 and held it in 1 quarter. The position peaked at $3.73M in Q4 2025. 247 funds tracked by Wall St. Rank hold DFTX as of Q1 2026.

  • Universal-Beteiligungs- und Servicegesellschaft reported no remaining Definium Therapeutics position as of Q1 2026 after selling out during the quarter.
  • Universal-Beteiligungs- und Servicegesellschaft sold 278,720 Definium Therapeutics shares in Q1 2026, an estimated $3.73M.
  • Universal-Beteiligungs- und Servicegesellschaft first reported a position in Definium Therapeutics in Q4 2025 and held it in 1 quarter.
  • Universal-Beteiligungs- und Servicegesellschaft's Definium Therapeutics position peaked at $3.73M in Q4 2025.
  • 247 funds tracked by Wall St. Rank held Definium Therapeutics as of Q1 2026.

Based on Universal-Beteiligungs- und Servicegesellschaft's 13F filing for Q1 2026, filed 11 May 2026.